Japanese Pharmaceutical Industry Realignment Speeds Up In 2008: Interview With President Of Dainippon Sumitomo
This article was originally published in PharmAsia News
Executive Summary
In an interview with Yomiuri News, Dainippon Sumitomo President Kenjiro Miyatake noted 2008 drug prices are estimated to be over five percent lower
You may also be interested in...
Danippon Sumitomo Deal With BioSeek Could Be Model For Other Japanese Pharmas – BIO-Asia
TOKYO - BioSeek's deal last week with Danippon Sumitomo Pharma could be a model for additional deals between the Burlington, Calif.-based platform company and Japanese pharmas looking to de-risk preclinical decisions, according to BioSeek VP-Technology & Alliances Ivan Plavec
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.